Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial

PaperCitations, authors & open-access status

Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,028 citations, 2023 year and closed oa status.

1,028
Citations
2023
Year
closed
OA Status

Related on ScholarIQ

Axel Haupt
Author
New England Journal of Medicine
Journal
Diabetes Treatment and Management
Topic
Diabetes Treatment and Management
Topic
Bariatric Surgery and Outcomes
Topic
Pharmacology and Obesity Treatment
Topic
470M+ articles · free account